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Abstract  
Introduction: In Sub-Saharan Africa, few studies reported pregnancy incidence and outcomes in women taking antiretroviral therapy (ART). This 
survey aims to estimate the incidence and outcomes of pregnancy in a cohort of HIV positive women initiating ART in Bobo-Dioulasso, Burkina 
Faso. Methods: We carried out a retrospective cohort study. We selected women in childbearing age initiating ART and followed up in Bobo-
Dioulasso teaching hospital between January 2005 and June 2011. The incidence of pregnancies during follow-up was calculated. Childbirth was 
defined by the expulsion of a fetus after 22 weeks of amenorrhea. Before this term, it is an abortion. Childbirth is said premature if it occurs before 
37 weeks of gestation, to term if it occurs between the 38th and the 42nd week. The annual age-standardized fertility rates were calculated using 
the baseline population from the 2010 demographic and health survey (DHS) in Burkina Faso. Results: A total of 1,763 women of childbearing 
age under ART were included in the study. They ranged between 18 and 48 years old with a median of 35 years old. A total of 222 pregnancies 
were observed during 4639 women-years of follow-up, corresponding to an incidence density of 5 pregnancies for 100 women-years (95% CI: 4.2-
5.5). Among the 222 pregnancies recorded, 9(4.0%) ended with abortion, 205(92.4%) with childbirth (including 15 premature childbirths); the 
outcome of 8(3.6 %) pregnancies were unknown abortion. Live birth and stillborn rates were 94.0% (193/205) and 6.0% respectively. The 
standard fertility rate in our cohort was 45 live births for 1,000 women-years. The general decrease in fertility rates was 66.0% among women 
infected with HIV compared to the overall population Conclusion: This study shows a low pregnancy incidence among women initiating ART as 
compared to their peers from the general population. Pregnancies that occurred during ART generally end with live births. Care packages for HIV 
infected women of childbearing age must include reproductive health services to better address this issue. 
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Introduction 
 
Sub-Saharan Africa is the most HIV affected area, with women as 
the most vulnerable population. Indeed, 58% of people living with 
HIV/AIDS (PLWHA) in Sub-Saharan Africa was women of 
childbearing age [1]. Improving life expectancy and quality for 
PLWHA on antiretroviral therapy (ART) increases their desire for 
bearing children [2-7] even though HIV infection is associated with 
a 25 to 40% decrease in fertility among women of childbearing age 
[8-10]. Pregnancy is not likely to influence the progression of the 
infection [11]. Additionally, as long as the mother is in good health, 
HIV does not impact the course of the pregnancy [12]. The risks of 
complications are higher for the mother and her fetus when mother 
develops an HIV-related opportunistic disease and when the CD4 
cells count is below 200/µl [13]. Miscarriages, abortions, ectopic 
pregnancies and stillborns delivery seem to be as recurrent among 
HIV positive women (some of whom were under ART) as among 
non infected women [8, 14-16]. According to the UNAIDS Report on 
Global AIDS Epidemic, 60% of HIV-infected people in Burkina Faso 
are women of childbearing age [17]. Besides, the desire for bearing 
children is quite high among women in general in Burkina Faso 
including HIV infected women [18]. However, there are little data 
on the frequency of pregnancies among HIV-infected women under 
antiretroviral treatment. We therefore deemed it necessary to study 
the incidence and outcome of pregnancies in Bobo-Dioulasso Day 
Hospital cohort. Knowing the status of women under ART who get 






Framework and period of the study: the study was conducted 
from January 1st, 2005 to June 30, 2011 at the Souro Sanou 
Teaching Hospital, Bobo-Dioulasso, a public referral hospital in 
Burkina Faso offering outpatient care services to people living with 
HIV [19]. 
 
Type of study: this is a retrospective cohort study. 
 
Targeted population: patients targeted in the study include non 
pregnant women of childbearing age (18- 49 years) under 
antiretroviral treatment between January 2005 and December 2010. 
They were followed up until June 30, 2011 (reference date). 
Data collection: data for the follow up of people living with HIV 
were collected at Bobo-Dioulasso day hospital using the ESOPE 
software that was regularly filled in by doctors during medical visits. 
The socio-demographic, biological and therapeutic data of the study 
were taken from ESOPE database. For the diagnosis of pregnancies, 
immunologic tests (BBtestR) were conducted at the beginning of the 
antiretroviral treatment and at the occurrence of amenorrhea during 
the follow up. Positive pregnancy tests were confirmed by pelvic 
scan. Pregnancy development and outcome-related data were 
collected from patients' antenatal care records. Childbirth was 
defined by the expulsion of a fetus after 22 weeks of amenorrhea. 
Before this term, it is an abortion. Childbirth is said premature if it 
occurs before 37 weeks of gestation, to term if it occurs between 
the 38th and the 42nd week. 
 
Data analysis: the data collected were analyzed using STATA 
version 12. A description of the socio-demographic, biological and 
clinical characteristics of the survey population was made. Common 
statistics including the median and inter quartile range (IQR) and 
percentages (%) were used to describe the survey population. The 
exact Fischer test was used to compare proportions, while Student t 
test served to compare continuous variables. The pregnancy 
incidence was estimated from the number of pregnancies based on 
the sum of observation periods for each patient. Only the first 
pregnancies under ART were considered in calculating the 
incidence. The pregnancy occurrence risk according to the ART time 
was estimated using the Kaplan Meier method. The outcome of 
pregnancies was described. The fertility rate in terms of number of 
live births for 1,000 women was estimated in the survey population. 
The annual age-standardized rates (indirect standardization) were 
calculated using the baseline population from the 2010 demographic 
and health survey (DHS) in Burkina Faso [10]. The agreed 
significance threshold was 5% for all analyses. 
 
Ethical considerations: this observational study was conducted 
as part of the routine care services and therefore presented no risk 
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Results 
 
Socio-demographic characteristics of the survey 
population: On December 31st, 2010 a total number of 2,717 
patients including 74.0% women were under antiretroviral 
treatment. Between January 2005 and December 2010, a total of 
1,763 women of childbearing age under ART were included in the 
cohort survey. They were aged between 18 and 48 years with a 
median age of 35 years (IQR: 30-40). Almost half of the patients 
(49.0%) were aged between 30 and 39. Table 1 summarizes the 
socio-demographic characteristics of the patients. They were mainly 
uneducated (42.5%; n=749), unemployed (75.7%; n=1334), 
almost 44.6% (n=787) living as a couple. The average number of 
children per woman was 2 (IQR: 2-3) with 0 and 9 children as the 
extremes. More than half of the women (52%; n=919) had at least 
two children. 
 
Biological and therapeutic characteristics: HIV-1 infection and 
combined HIV-1+2 infection respectively represented 94.2% and 
4.0% of cases. At the beginning of the antiretroviral combined 
therapy, the median of CD4 cell count was 126 c/µl (IQR: 70-213 
cells/µl); with extremes (1- 412 cells/µl); more than two-thirds 
(70.7%; n=1,246) of patients had less than 200 CD4 cells count. 
The combination of two nucleoside reverse transcriptase inhibitors 
(NRTI) plus one non-nucleoside inhibitor of reverse transcriptase 
(NNRTI) was prescribed as first line therapy in 85.7% of cases and 
2 NRTI+1 PI (protease inhibitor) in 14.2% of cases. Nevirapine was 
the most commonly prescribed (54.1%) medication. Out of the 
1,763 women of childbearing age, 558 (31.6%) were under ART 
which includes Efavirenz. The average duration of the follow up 
period was 29 months (IQR: 13-48 months) with extremes (1 - 74 
months). 
 
Incidence of pregnancies in the cohort: Throughout the study, 
222 pregnancies were observed among 1,763 women, with a follow-
up of 4,639 women-years, corresponding to an incidence density of 
5 pregnancies for 100 women-years (IC 95%: 4, 2-5, 5). The 
median time between the beginning of the ART and the occurrence 
of the pregnancy was 19 months (IQR: 9-36 months). The incidence 
of the pregnancy increased with the length of the exposure to the 
treatment; it was respectively 1.4%, 4.2% and 9.1% women-years 
at 6, 12 and 24 months of treatment. Among the 558 patients under 
Efavirenz, 46 (8.2%) became pregnant. Only 18 had their treatment 
changed due to the pregnancy. Efavirenz was replaced by 
Nevirapine or Lopinavir boosted with Ritonavir. 
 
Outcome of pregnancies: No information on the outcome 8 out 
of 222 pregnancies (3.6%) was recorded. The outcome of 214 
pregnancies was registered and resulted in 9 cases of abortion 
(4.0%); with a median gestational age of 12 weeks of amenorrhea 
(IQR, 8-13); 205 pregnancies (92.4%) resulted in childbirths 
including 15 premature childbirths. Natural delivery represent 
90.2%, (185/205) compared to 9.8% (20/205) caesarean sections. 
The frequency of live births and stillborns was respectively 94.0% 
(193/205) and 6.0% (12/205). Babies' median weight was 2,800g 
(IQR: 2,550g; 3,100g); 30 babies (representing 14.6% of live 
births) were born with less than the median weight (below 2,500g). 
 
Fertility rate of HIV infected patients: Table 2 provides details 
of the age-standardized fertility rate and standardized incidence 
ratios. The standardized crude fertility rate in our cohort was 45 live 
births for 1,000 women-years. The fertility rate has changed in all 
age groups of PLWHA compared to the baseline, except for the 15 
to 19 years old group. The standardized incidence ratios (SIR) are 
low and the overall decrease in fertility was 66.0% compared to the 
entire population. According to the age groups, this decrease in 





This retrospective study has some limitations. Despite it is 
condemned by the law in Burkina Faso, pregnancy termination is 
still performed. Therefore, we cannot assert that all cases of 
pregnancy have been registered. However, this innovative study 
made it possible to assess the frequency of pregnancies among 
patients on ART in Burkina Faso. The incidence of pregnancy was 5 
for 100 women-years. However, this number is below most of rates 
found in African studies [8,9,20-23] with a frequency ranging from 
7.9 to 24.6 for 100 women-years. The incidence of pregnancy could 
vary from one study to another depending on how patients are 
selected and on the pregnancy diagnosis criteria as well. The 
relative high number of our patients (median age 35) and the low 
proportion of people living as husband and wife (44.6%) could 
account for the low frequency of pregnancies in our study. 
Performing systematic and regular pregnancy tests would help 
determine the number of pregnancies ending up into miscarriage. 
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The proportion of abortion was 4.0% (n=9) in our study. It is lower 
compared to that reported by Homsy et al. [24] in Uganda and 
Bussman et al. [8] in Botswana, respectively with 58.6% and 
42.3%. High abortion prevalence in the two later surveys was due 
to the high number of induced abortion. The information collected 
as part of our study does not enable us to differentiate spontaneous 
abortion (miscarriages) from induced abortions. In our survey, live 
births represent 94.0%. A total of 12 stillborns were recorded, 
representing 6.0% of pregnancies. Our results are close to those 
found by Ekouevi et al. [25] in Côte d'Ivoire and Liu et al [26] in 
South Africa and Zambia. The median weight of babies born from 
mothers under ART was 2,800g, whereas the lower weight was 
14.6% for live babies. The finding of our investigations is close to 
those made by researchers from sub-Saharan Africa [8, 25-27]. 
Some of them related low weight at birth to mothers undergoing an 
antiretroviral treatment [28]. However, the findings of studies 
conducted on this issue remain quite controversial. This study shows 
a 15 to 70% decrease in fertility rates among HIV infected women 
compared to the overall population, except for the age group of 15 
to 19. This corroborates the findings from existing literature papers 
[10,29]. Poor information provided to patients in relation with the 
impact of antiretroviral treatment on reduction of mother-to-child 
transmission and high frequency of non severe amenorrhea during 
the infection could account for the decrease in fertility among those 
women. Low fertility can also be explained by the increased use of 
condoms by HIV infected women fearing to pass on the infection 
[30]. PLWHA care services should provide them reproductive health 
care in order to help those women exercise their sexual and 
reproductive rights in the best and safe conditions both for the 





This study highlights a low pregnancy incidence among women 
under art compared to the population in general. Women who 
became pregnant while on ART treatment delivered live babies in 
most cases. The care package for HIV infected women of 
childbearing age should include reproductive services. Women 
willing to give birth must be supported through counseling and with 
health care to ensure better conditions for the couple and the fetus. 
The follow up of such pregnancies should involve specialists of 
infection, obstetricians, and pediatricians collaborating for more 
favorable outcome. 
 
What is known about this topic 
 Before the era of high active antiretroviral therapy 
(HAART), HIV infection evolved inescapable way to short 
or medium term towards death. 
 Today, thanks to HAART mother to child transmission of 
HIV is practically zero and PLWHA in therapeutic success 
have a quality and a life expectancy comparable to 
persons HIV negative. . 
 However reproductive issues are little discussed by 
practitioners working in HIV care centers in Burkina Faso. 
The latter being shared between the obligation to 
promote the prevention of horizontal transmission of HIV 
(wearing a condom) and the need to inform patients 
about the possibility of conceiving an HIV-negative child 
with ARV treatment. 
 
What this study adds 
 This study highlights a low pregnancy incidence among 
women under ART compared to the population in general. 
 The standardized incidence ratios (SIR) are low and the 
overall decrease in fertility was 66.0% compared to the 
entire population. 
 Women who became pregnant while under ART delivered 
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20 - 24 
(n=98) 
25 - 29 
(n=300) 
30 - 34 
(n=416) 
35 - 39 
(n=448) 




Profession (%)                
Unemployed 4(50.0) 74(75.5) 225(75.0) 315(75.7) 333(74.3) 233(77.9) 150(77.3) 1334(75.7) 
Trader        0 8(8.2) 25(8.3) 42(9.9) 42(9.4) 25(8.4) 20(10.3) 161(9.1) 
Civil servant 0 2(2.0) 18(6.0) 30(7.2) 42(9.4) 26(8.7) 11(5.7) 129(7.3) 
Other 4(50.0) 14(14.3) 32(10.7) 30(7.2) 31(6.9) 15(5.0) 13(6.7) 139(7.9) 
Level of education 
(%) 
               
None 3(37.5) 42(42.9) 105(35.0) 158(38.0) 191(42.6) 146(48.8) 104(53.6) 749(42.5) 
Primary school 2(25.0) 38(38.8) 102(34.0) 134(31.7) 112(25.0) 88(29.4) 63(32.5) 537(30.5) 


















No information 0 2(2.0) 3(1.0) 2(0.5) 6(1.4) 2(0.7) 4(2.0) 19(1.0) 
Marital status (%)                
Living in couple 4(50.0) 37(37.8) 134(44.7) 211(50.7) 207(46.2) 123(41.1) 71(36.6) 787(44.6) 
Single 3(37.5) 37(37.8) 107(35.7) 97(23.3) 82(18.3) 37(12.4) 14(7.2) 377(21.4) 
Widow 1(12.5) 20(20.4) 37(12.3) 79(19.0) 127(28.4) 108(36.1) 86(44.3) 458(26.0) 
Divorced 0 4(4.0) 22(7.3) 29(7.0) 32(7.1) 31(10.4) 23(11.9) 141(8.0) 
Number of live 
children (%) 
               
0 – 1 8(100) 72(73.5) 210(70.0) 213(51.2) 165(36.8) 84(28.1) 30(15.5) 782(44.4) 
2 – 4 0 19(19.4) 67(22.3) 184(44.2) 235(52.5) 158(52.8) 96(48.0) 756(42.9) 
>4 0 0 2(0.7) 8(1.9) 31(6.9) 54(18.1) 68(35.0) 163(9.2) 
No information 0 7(7.1) 21(7.0) 11(2.6) 17(3.8) 3(1.0) 3(1.5) 62 (3.5) 
Type of HIV (%)                
HIV-1 8(100) 94(95.9) 289(96.3) 398(95.7) 429(95.8) 273(91.3) 170(87.6) 1661(94.2) 
HIV-2 0 0 2(0.7) 4(1.0) 7(1.5) 6(2.0) 13(6.7) 32(1.8) 
HIV-1+2 0 4(4.1) 9(3.0) 14(3.3) 12(2.7) 20(6.7) 11(5.7) 70(4.0) 
Initial CD4 T cell 
count (cells/µL) (%) 
                
< 200 4(50.0) 62(63.3) 218(72.7) 286(68.8) 322(71.9) 218(72.9) 136(70.1) 1246(70.7) 
≥200 4(50.0) 36(36.7) 82(27.3) 130(31.2) 126(28.1) 81(27.1) 58(29.9) 517(29.3) 
ART (%)                 
2 NRTIs +1 IP 3(37.5) 11(11.2) 37(12.3) 61(14.7) 61(13.6) 48(16.0) 30(15.5) 251(14.2) 
2NRTIs +1 NNRTI 5(62.5) 87(88.8) 263(87.7) 355(85.3) 387(86.4) 251(84.0) 164(84.5) 1512(85.8) 
ART: antiretroviral therapy; NRTIs: nucleoside reverse transcriptase inhibitors; NNRTI: non-nucleoside reverse transcriptase inhibitor; PI: protease 
inhibitor. 
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Table 2: Number of newborns, incidence ratio and age-standardized fertility rate of women on ART at the Bobo-Dioulasso Day 
Care Unit, Souro Sanou Teaching Hospital, Burkina Faso, 2005-2011* 
  Baseline 
population 
People living with HIV 
Age 
(years) 










Standardized fertility rates 
for 1000 women-years 
15 - 19 69 1 1 1.00 69.0 
20 - 24 167 40 18 0.45 75.1 
25 - 29 186 135 43 0.32 59.5 
30 - 34 180 198 60 0.30 54 
35 - 39 120 144 47 0.33 39.6 
40 - 44 48 39 18 0.46 22.1 
45- 49 15 8 6 0.75 11.2 
Total 132 565 193 0.34 45.0 
*Indirect standardization using Demographic and Health Survey, Burkina Faso, 2010 
 
